Cabot (CBT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $74.29, -1.58% vs the prior close of $75.48.
- Volume 317.29K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CBT dips 1.6% to $74.29. Closed at $74.29, -1.58% vs the prior close of $75.48. Day range $73.99–$76.65, opened at $75.66.
CBT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CBT dips 1.6% to $74.29
- Closed at $74.29, -1.58% vs the prior close of $75.48. Day range $73.99–$76.65, opened at $75.66.
- Volume was 317.29K shares, 0.8x its 50-day average of 387.75K.
- Price is -7.6% vs its 50-day average ($80.44) and -6.4% vs its 200-day average ($79.37).
- 52-week range $58.33–$94.53; today's close sits at 44% of that range, 21.4% below the 52-week high.
Oct 15, 2026 — CBT rises 0.4% to $75.48
- Closed at $75.48, +0.44% vs the prior close of $75.15. Day range $75.27–$76.35, opened at $75.99.
- Volume was 321.20K shares, 0.8x its 50-day average of 398.20K.
- Price is -6.5% vs its 50-day average ($80.70) and -4.9% vs its 200-day average ($79.33).
- 52-week range $58.33–$94.53; today's close sits at 47% of that range, 20.2% below the 52-week high.
Oct 14, 2026 — CBT dips 0.4% to $75.15
- Closed at $75.15, -0.42% vs the prior close of $75.47. Day range $74.36–$75.52, opened at $74.94.
- Volume was 377.90K shares, 0.9x its 50-day average of 420.20K.
- Price is -7.1% vs its 50-day average ($80.89) and -5.2% vs its 200-day average ($79.29).
- 52-week range $58.33–$94.53; today's close sits at 46% of that range, 20.5% below the 52-week high.
Oct 13, 2026 — CBT rises 1.6% to $75.47
- Closed at $75.47, +1.63% vs the prior close of $74.26. Day range $74.25–$75.66, opened at $74.27.
- Volume was 298.50K shares, 0.7x its 50-day average of 425.25K.
- Price is -6.9% vs its 50-day average ($81.02) and -4.8% vs its 200-day average ($79.24).
- 52-week range $58.33–$94.53; today's close sits at 47% of that range, 20.2% below the 52-week high.
Oct 12, 2026 — CBT dips 0.9% to $74.26, a 3-month low
- Closed at $74.26, -0.87% vs the prior close of $74.91. Day range $74.07–$75.46, opened at $74.63.
- Volume was 352.70K shares, 0.8x its 50-day average of 427.29K.
- Price is -8.7% vs its 50-day average ($81.30) and -6.2% vs its 200-day average ($79.20).
- 52-week range $58.33–$94.53; today's close sits at 44% of that range, 21.4% below the 52-week high.
Oct 9, 2026 — CBT dips 0.9% to $74.91, a 3-month low
- Closed at $74.91, -0.93% vs the prior close of $75.61. Day range $74.50–$75.64, opened at $75.27.
- Volume was 285.60K shares, 0.7x its 50-day average of 433.50K.
- Price is -8.2% vs its 50-day average ($81.58) and -5.4% vs its 200-day average ($79.15).
- 52-week range $58.33–$94.53; today's close sits at 46% of that range, 20.8% below the 52-week high.
Oct 8, 2026 — CBT ends flat (+0.3%) to $75.61
- Closed at $75.61, +0.27% vs the prior close of $75.41. Day range $74.78–$76.41, opened at $75.58.
- Volume was 363.20K shares, 0.8x its 50-day average of 433.77K.
- Price is -7.6% vs its 50-day average ($81.85) and -4.4% vs its 200-day average ($79.11).
- 52-week range $58.33–$94.53; today's close sits at 48% of that range, 20.0% below the 52-week high.
Oct 7, 2026 — CBT dips 2.2% to $75.41, a 3-month low
- Closed at $75.41, -2.20% vs the prior close of $77.11. Day range $75.36–$76.91, opened at $76.67.
- Volume was 420.40K shares, 1.0x its 50-day average of 430.49K.
- Price is -8.2% vs its 50-day average ($82.16) and -4.6% vs its 200-day average ($79.06).
- 52-week range $58.33–$94.53; today's close sits at 47% of that range, 20.2% below the 52-week high.
Oct 6, 2026 — CBT dips 0.3% to $77.11
- Closed at $77.11, -0.35% vs the prior close of $77.38. Day range $76.64–$77.74, opened at $76.87.
- Volume was 419.00K shares, 1.0x its 50-day average of 428.61K.
- Price is -6.5% vs its 50-day average ($82.48) and -2.4% vs its 200-day average ($79.02).
- 52-week range $58.33–$94.53; today's close sits at 52% of that range, 18.4% below the 52-week high.
Oct 5, 2026 — CBT rises 0.6% to $77.38
- Closed at $77.38, +0.56% vs the prior close of $76.95. Day range $75.10–$78.13, opened at $76.67.
- Volume was 496.00K shares, 1.2x its 50-day average of 422.81K.
- Price is -6.5% vs its 50-day average ($82.72) and -2.0% vs its 200-day average ($78.97).
- 52-week range $58.33–$94.53; today's close sits at 53% of that range, 18.1% below the 52-week high.
Oct 2, 2026 — CBT rises 0.8% to $76.95
- Closed at $76.95, +0.79% vs the prior close of $76.35. Day range $76.93–$78.68, opened at $77.67.
- Volume was 376.70K shares, 0.9x its 50-day average of 421.42K.
- Price is -7.3% vs its 50-day average ($82.98) and -2.5% vs its 200-day average ($78.93).
- 52-week range $58.33–$94.53; today's close sits at 51% of that range, 18.6% below the 52-week high.
CBT latest news & SEC filings
Every SEC filing by or about CBT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form 424B2 — Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $982.00M (prior year $923.00M) (+6.4% vs Jun 30, 2025)
- Net income: $6.00M (prior year $101.00M) (-94.1% vs Jun 30, 2025)
- Diluted EPS: $0.12 (prior year $1.86) (-93.5% vs Jun 30, 2025)
Things to know before you trade CBT
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 3, 2026, Nov 3, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.96% (largest 3.8%). That is a relatively calm stock.
- Liquidity: about 381.77K shares (≈$28.36M) trade per day on average.
- 52-week position: $74.29 vs a range of $58.33–$94.53 (44% of the range).
- Dividends: last ex-dividend date Aug 28, 2026 ($0.473/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Sean D Keohane sold 134,895 shares on Aug 28, 2026.
- Latest filings: 8-K Sep 15, 2026; 8-K Aug 21, 2026; 8-K Aug 14, 2026.
- Share count: 51.63M shares outstanding (Jul 31, 2026), -3.0% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Miscellaneous Chemical Products.
CBT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 75.66 | 76.65 | 73.99 | 74.29 | 317.29K |
| Oct 15, 2026 | 75.99 | 76.35 | 75.27 | 75.48 | 321.20K |
| Oct 14, 2026 | 74.94 | 75.52 | 74.36 | 75.15 | 377.90K |
| Oct 13, 2026 | 74.27 | 75.66 | 74.25 | 75.47 | 298.50K |
| Oct 12, 2026 | 74.63 | 75.46 | 74.07 | 74.26 | 352.70K |
| Oct 9, 2026 | 75.27 | 75.64 | 74.50 | 74.91 | 285.60K |
| Oct 8, 2026 | 75.58 | 76.41 | 74.78 | 75.61 | 363.20K |
| Oct 7, 2026 | 76.67 | 76.91 | 75.36 | 75.41 | 420.40K |
| Oct 6, 2026 | 76.87 | 77.74 | 76.64 | 77.11 | 419.00K |
| Oct 5, 2026 | 76.67 | 78.13 | 75.10 | 77.38 | 496.00K |
| Oct 2, 2026 | 77.67 | 78.68 | 76.93 | 76.95 | 376.70K |
| Oct 1, 2026 | 76.50 | 77.14 | 74.55 | 76.35 | 606.60K |
| Sep 30, 2026 | 77.94 | 78.02 | 76.76 | 76.91 | 570.10K |
| Sep 29, 2026 | 78.65 | 78.65 | 77.65 | 77.76 | 362.90K |
| Sep 28, 2026 | 78.19 | 79.29 | 77.50 | 78.45 | 370.70K |
| Sep 25, 2026 | 78.52 | 80.11 | 78.43 | 78.76 | 413.80K |
| Sep 24, 2026 | 78.52 | 78.92 | 77.76 | 78.65 | 293.60K |
| Sep 23, 2026 | 79.09 | 80.04 | 78.75 | 78.80 | 335.80K |
| Sep 22, 2026 | 77.39 | 79.96 | 77.39 | 79.47 | 340.20K |
| Sep 21, 2026 | 77.88 | 77.88 | 76.21 | 76.59 | 313.20K |
About Cabot
Cabot (CBT) is listed on the NYSE and classified by the SEC under “Miscellaneous Chemical Products”. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends September 30. SEC CIK 16040.
CBT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Cynthia A Arnold | Director | Jan 12, 2026 |
| Douglas G Delgrosso | Director | Sep 14, 2026 |
| Cabot Juan Enriquez | Director | Jan 12, 2026 |
| Sean D Keohane | President and CEO | Sep 14, 2026 |
| William C. Kirby | Director | Jan 12, 2026 |
| Michael M Morrow | Director | Jan 12, 2026 |
| Raffiq Nathoo | Director | Sep 14, 2026 |
| Thierry Fj Vanlancker | Director | Jan 12, 2026 |
| Michelle Elizabeth Williams | Director | Jan 12, 2026 |
| Frank Anders Wilson | Director | Jan 12, 2026 |
| Christine Y Yan | Director | Jan 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lisa M Dumont | VP, Controller & CAO | Sep 14, 2026 |
| Karen A Kalita | SVP and General Counsel | Sep 14, 2026 |
| Sean D Keohane | President and CEO | Sep 14, 2026 |
| William F Iii Masterson | Senior Vice President | Sep 14, 2026 |
| Erica Mclaughlin | Executive Vice President, CFO | Sep 14, 2026 |
| Matthew Forster Wood | Senior Vice President | Nov 21, 2025 |
| Jeff Ji Zhu | Executive Vice President | Nov 21, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Sean D Keohane | Sale | 134,895 | $85.00 |
| Aug 28, 2026 | Sean D Keohane | Sale | 134,895 | $85.00 |
| Aug 28, 2026 | Sean D Keohane | Sale | 134,895 | $85.00 |
| Aug 28, 2026 | Sean D Keohane | Sale | 134,895 | $85.00 |
| Aug 24, 2026 | Sean D Keohane | Sale | 2,779 | $85.50 |
| Aug 24, 2026 | Sean D Keohane | Sale | 2,779 | $85.50 |
| Aug 24, 2026 | Sean D Keohane | Sale | 2,779 | $85.50 |
| Aug 24, 2026 | Sean D Keohane | Sale | 2,779 | $85.50 |
| Aug 7, 2026 | Sean D Keohane | Sale | 91,923 | $86.41 |
| Aug 7, 2026 | Sean D Keohane | Sale | 91,923 | $86.41 |
| Aug 7, 2026 | Sean D Keohane | Sale | 91,923 | $86.41 |
| Aug 7, 2026 | Sean D Keohane | Sale | 91,923 | $86.41 |
CBT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | $3.71B | $331.00M | 6.02 | $665.00M |
| Sep 30, 2024 | $3.99B | $380.00M | 6.72 | $692.00M |
| Sep 30, 2023 | $3.93B | $445.00M | 7.73 | $595.00M |
| Sep 30, 2022 | $4.32B | $209.00M | 3.62 | $100.00M |
| Sep 30, 2021 | $3.41B | $250.00M | 4.34 | $257.00M |
Latest balance sheet: total assets $3.98B, total liabilities $—, cash $250.00M (as of Jun 30, 2026).
CBT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $89.58 |
| May 5, 2026 | 8-K Item 2.02 (results) | $78.93 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $71.29 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $65.90 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $73.71 |
| May 6, 2025 | 8-K Item 2.02 (results) | $72.47 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $88.19 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $110.09 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 5, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Miscellaneous Chemical Products
Element Solutions (ESI)Wd 40 (WDFC)Flotek Industries (FTK)ASP Isotopes (ASPI)Orion (OEC)Arq (ARQ)Flexible Solutions International (FSI)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CBT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.